As the health care ecosystem continues to evolve, life sciences leaders across both the pharmaceutical and medical device industries must understand how their customers’ priorities are changing—and what that means for their customer engagement, evidence generation, and communication strategies.
In this series, we’re breaking down the top customer trends that life sciences leaders need to know about in 2022. In this installment, there are four hospital and IDN trends worth watching:
- Site-of-care shifts are expanding where drugs, diagnostics, and medical equipment are used and who has influence over product decisions.
- Telehealth utilization will continue to disperse where and how care is delivered in the post-Covid world, taking market share away from the hospital and/or health system.
- Ongoing disruptions to the supply chain will require life sciences leaders to build more resilient supply chains, prioritize collaboration and transparency when working with their provider customers, and redefine how they provide clinical support.
- The health care industry is investing heavily in home-based care, shifting inpatient medical admissions from the hospital to the home setting.
Read on to learn more about each trend and what it means for you.
Not a member? Download a copy here.